HC Wainwright & Co. Reiterates Buy on Aura Biosciences, Maintains $22 Price Target
Benzinga Newsdesk 7 months ago
NewsPrice TargetReiterationAnalyst Ratings
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Aura Biosciences (NASDAQ:AURA) with a Buy and maintains $22 price target.
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Aura Biosciences (NASDAQ:AURA) with a Buy and maintains $22 price target.